Commission Implementing Decision (EU) 2017/1445 Article 1

Article 1

The group of products whose principal intended action, depending on proanthocyanidins present in cranberry ( Vaccinium macrocarpon ) extract, is to prevent or treat cystitis, does not fall within the definition of medical devices set out in point (a) of Article 1(2) of Directive 93/42/EEC.

Read the full instrument →

Other provisions in Commission Implementing Decision (EU) 2017/1445

Article 2

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 1 of Commission Implementing Decision (EU) 2017/1445 (LawPlayer, data as of 2026-07-04)

What to look at next

Commission Implementing Decision (EU) 2017/1445, full textThe complete text of this law, so you can read this section in contextEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview